EMCDDA. New drugs in Europe, 2016, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 May 2017. 489 kB. #2
Montenarh, D; Hopf, M; Warth, S; Maurer, HH; Schmidt, P; Ewald, AH. A simple extraction and LC-MS/MS approach for the screening and identification of over 100 analytes in eight different matrices: Detection of 130 analytes in eight biosamples using only one LC-MS/MS method Drug Test. Anal., 1 Mar 2015, 7 (3), 214-240. 593 kB. https://doi.org/10.1002/dta.1657 LC,MS
N-(2-Methoxyethyl)-3,4-methylenedioxyamphetamine · N-Methoxyethyl-MDA · MDMEOET
4-Acetyl-2,5-dimethoxyamphetamine · DOAC
N-Me-2,5-DEPEA-βk · β-Keto-N-methyl-2,5-diethoxyphenethylamine
2,5-DEA-βk · 2,5-Diethoxycathinone
5,6,7-Trimethoxy-2-aminotetralin · TMAT
Gigantine (Earlier, incorrect structure)
4-Cyclopropoxy-3,5-dimethoxyphenethylamine · 4-cPrO-3,5-DMPEA · CP · Cycloproscaline
2,5-DMA-Ac · N-Acetyl 2,5-DMA · N-Acetyl 2,5-dimethoxyamphetamine
4-Allyloxy-2,6-dimethoxyphenethylamine · ψ-2C-O-16
2C-O-16 · 4-Allyloxy-2,5-dimethoxyphenethylamine
2,5-Dimethoxy-4-(oxetan-3-yl)phenethylamine · 2C-OXET3
5-Ac-DOM · 5-Acetoxy-2 methoxy-4-methylamphetamine
bk-2C-P · β-Keto-2,5-dimethoxy-4-propylphenethylamine
bk-2C-iP · β-Keto-4-isopropyl-2,5-dimethoxyphenethylamine
bk-MDOM · β-Keto-N-methyl-2,5-dimethoxy-4-methylamphetamine
2,5-Dimethoxy-4-(oxetan-2-yl)phenethylamine · 2C-OXET-2